Press release content from Newswire. The AP news staff was not involved in its creation.
FoodChain ID Acquires Viaware
DEERFIELD, Ill. - January 5, 2021 - ( Newswire.com )
FoodChain ID, a market-leading provider of technology-enabled food safety, quality, and sustainability solutions, has acquired Viaware, a leading cloud-based food contact risk assessment and integrated supply-chain-compliance-solutions provider. FoodChain ID is a portfolio company of Berkshire Partners.
Founded in 2013, with headquarters in The Netherlands, Viaware’s primary product is FOCOS®, a web-based application that helps businesses in the supply chain to manage and control compliance work and documentation. FOCOS enables food companies to manage packaging products and raw materials compliance, create customized Declarations of Compliance (DoCs), manage supporting documentation, and communicate with suppliers and customers in a single application. FOCOS integrates with ERP and PLM systems.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Hempstract Inc. Completes First Round of CBD Extraction
January 6, 2021 GMT
SEATTLE, WA / ACCESSWIRE / January 5, 2021 / Hempstract, Inc, (OTC PINK:HPST)(the “Company”), today announced it has completed the extraction process on 36,821 of raw hemp resulting in 4,050 pounds of extracted product. Representing a major milestone in the Company’s production and business development plans. The Company will be handling all pre-orders and market orders in house, to maximize sales revenues.
Richard Hawkins, the Company’s Chief Executive Officer, commented: “As a company we’ve seen an increase in demand for concentrates and we’re so thrilled to be kicking of the new year with the completion of this first extraction to begin to answer this increasing demand.”
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Kamada Selected as a Winner of the Genesis Prize Foundation and Start-Up Nation Central Competition
Kamada Ltd.January 5, 2021 GMT
REHOVOT, Israel, Jan. 05, 2021 (GLOBE NEWSWIRE) Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it has been selected as one of 10 winners of the Genesis Prize Foundation (GPF) Start-Up Nation Central (SNC) competition recognizing Israeli companies working to combat coronavirus and the damage of future pandemics. Based on its development of a plasma derived immunoglobulin (IgG) product as a potential therapy for coronavirus disease (COVID-19), Kamada was selected for its significant contributions towards fighting COVID-19 and advancing a promising technology that has the potential to provide significant benefits in the near future. The winners were announced in a virtual ceremony by Reuven Rivlin, President o